Literature DB >> 26051037

The gut microbiota and Type 1 Diabetes.

Elke Gülden1, F Susan Wong2, Li Wen3.   

Abstract

Type 1 Diabetes (T1D) is a multifactorial, immune-mediated disease, which is characterized by the progressive destruction of autologous insulin-producing beta cells in the pancreas. The risk of developing T1D is determined by genetic, epigenetic and environmental factors. In the past few decades there has been a continuous rise in the incidence of T1D, which cannot be explained by genetic factors alone. Changes in our lifestyle that include diet, hygiene, and antibiotic usage have already been suggested to be causal factors for this rising T1D incidence. Only recently have microbiota, which are affected by all these factors, been recognized as key environmental factors affecting T1D development. In this review we will summarize current knowledge on the impact of gut microbiota on T1D development and give an outlook on the potential to design new microbiota-based therapies in the prevention and treatment of T1D.
Copyright © 2015. Published by Elsevier Inc.

Entities:  

Keywords:  Gut microbiota; Gut permeability; Th17 cells; Treg; Type 1 Diabetes

Mesh:

Year:  2015        PMID: 26051037      PMCID: PMC4761565          DOI: 10.1016/j.clim.2015.05.013

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  104 in total

1.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.

Authors:  Yukihiro Furusawa; Yuuki Obata; Shinji Fukuda; Takaho A Endo; Gaku Nakato; Daisuke Takahashi; Yumiko Nakanishi; Chikako Uetake; Keiko Kato; Tamotsu Kato; Masumi Takahashi; Noriko N Fukuda; Shinnosuke Murakami; Eiji Miyauchi; Shingo Hino; Koji Atarashi; Satoshi Onawa; Yumiko Fujimura; Trevor Lockett; Julie M Clarke; David L Topping; Masaru Tomita; Shohei Hori; Osamu Ohara; Tatsuya Morita; Haruhiko Koseki; Jun Kikuchi; Kenya Honda; Koji Hase; Hiroshi Ohno
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

2.  Oral delivery of glutamic acid decarboxylase (GAD)-65 and IL10 by Lactococcus lactis reverses diabetes in recent-onset NOD mice.

Authors:  Sofie Robert; Conny Gysemans; Tatiana Takiishi; Hannelie Korf; Isabella Spagnuolo; Guido Sebastiani; Karolien Van Huynegem; Lothar Steidler; Silvia Caluwaerts; Pieter Demetter; Clive H Wasserfall; Mark A Atkinson; Francesco Dotta; Pieter Rottiers; Tom L Van Belle; Chantal Mathieu
Journal:  Diabetes       Date:  2014-03-27       Impact factor: 9.461

3.  Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota.

Authors:  June L Round; Sarkis K Mazmanian
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

4.  Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns.

Authors:  Maria G Dominguez-Bello; Elizabeth K Costello; Monica Contreras; Magda Magris; Glida Hidalgo; Noah Fierer; Rob Knight
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

5.  Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 years.

Authors:  Kevan C Herold; Stephen Gitelman; Carla Greenbaum; Jennifer Puck; William Hagopian; Peter Gottlieb; Peter Sayre; Peter Bianchine; Emelita Wong; Vicki Seyfert-Margolis; Kasia Bourcier; Jeffrey A Bluestone
Journal:  Clin Immunol       Date:  2009-05-14       Impact factor: 3.969

6.  Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers.

Authors:  Luying Peng; Zhong-Rong Li; Robert S Green; Ian R Holzman; Jing Lin
Journal:  J Nutr       Date:  2009-07-22       Impact factor: 4.798

7.  Innate immunity and intestinal microbiota in the development of Type 1 diabetes.

Authors:  Li Wen; Ruth E Ley; Pavel Yu Volchkov; Peter B Stranges; Lia Avanesyan; Austin C Stonebraker; Changyun Hu; F Susan Wong; Gregory L Szot; Jeffrey A Bluestone; Jeffrey I Gordon; Alexander V Chervonsky
Journal:  Nature       Date:  2008-09-21       Impact factor: 49.962

8.  Consumption of acidic water alters the gut microbiome and decreases the risk of diabetes in NOD mice.

Authors:  Kyle J Wolf; Joseph G Daft; Scott M Tanner; Riley Hartmann; Ehsan Khafipour; Robin G Lorenz
Journal:  J Histochem Cytochem       Date:  2014-01-22       Impact factor: 2.479

9.  Oral administration of recombinant Lactococcus lactis expressing HSP65 and tandemly repeated P277 reduces the incidence of type I diabetes in non-obese diabetic mice.

Authors:  Yanjun Ma; Jingjing Liu; Jing Hou; Yuankai Dong; Yong Lu; Liang Jin; Rongyue Cao; Taiming Li; Jie Wu
Journal:  PLoS One       Date:  2014-08-26       Impact factor: 3.240

10.  Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice.

Authors:  Juliet A Emamaullee; Joy Davis; Shaheed Merani; Christian Toso; John F Elliott; Aducio Thiesen; A M James Shapiro
Journal:  Diabetes       Date:  2009-03-16       Impact factor: 9.461

View more
  55 in total

1.  Self or non-self? The multifaceted role of the microbiota in immune-mediated diseases.

Authors:  Martin A Kriegel
Journal:  Clin Immunol       Date:  2015-05-21       Impact factor: 3.969

Review 2.  Mapping the microbial interactome: Statistical and experimental approaches for microbiome network inference.

Authors:  Anders B Dohlman; Xiling Shen
Journal:  Exp Biol Med (Maywood)       Date:  2019-03-16

Review 3.  Risk of Type 1 Diabetes in the Offspring Born through Elective or Non-elective Caesarean Section in Comparison to Vaginal Delivery: a Meta-Analysis of Observational Studies.

Authors:  Justine Tanoey; Amit Gulati; Chris Patterson; Heiko Becher
Journal:  Curr Diab Rep       Date:  2019-11-11       Impact factor: 4.810

Review 4.  Metabolomics in childhood diabetes.

Authors:  Brigitte I Frohnert; Marian J Rewers
Journal:  Pediatr Diabetes       Date:  2015-09-30       Impact factor: 4.866

Review 5.  Environmental risk factors for type 1 diabetes.

Authors:  Marian Rewers; Johnny Ludvigsson
Journal:  Lancet       Date:  2016-06-04       Impact factor: 79.321

6.  Inhalational exposure to particulate matter air pollution alters the composition of the gut microbiome.

Authors:  Ece A Mutlu; Işın Y Comba; Takugo Cho; Phillip A Engen; Cemal Yazıcı; Saul Soberanes; Robert B Hamanaka; Recep Niğdelioğlu; Angelo Y Meliton; Andrew J Ghio; G R Scott Budinger; Gökhan M Mutlu
Journal:  Environ Pollut       Date:  2018-05-18       Impact factor: 8.071

7.  Gut Microbiota Dysbiosis Enhances Migraine-Like Pain Via TNFα Upregulation.

Authors:  Yuanyuan Tang; Sufang Liu; Hui Shu; Lora Yanagisawa; Feng Tao
Journal:  Mol Neurobiol       Date:  2019-08-04       Impact factor: 5.590

Review 8.  The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota.

Authors:  Christian Milani; Sabrina Duranti; Francesca Bottacini; Eoghan Casey; Francesca Turroni; Jennifer Mahony; Clara Belzer; Susana Delgado Palacio; Silvia Arboleya Montes; Leonardo Mancabelli; Gabriele Andrea Lugli; Juan Miguel Rodriguez; Lars Bode; Willem de Vos; Miguel Gueimonde; Abelardo Margolles; Douwe van Sinderen; Marco Ventura
Journal:  Microbiol Mol Biol Rev       Date:  2017-11-08       Impact factor: 11.056

Review 9.  Viral infections in type 1 diabetes mellitus--why the β cells?

Authors:  Anne Op de Beeck; Decio L Eizirik
Journal:  Nat Rev Endocrinol       Date:  2016-03-29       Impact factor: 43.330

Review 10.  Harnessing the power of regulatory T-cells to control autoimmune diabetes: overview and perspective.

Authors:  Hua Yu; Ricardo Paiva; Richard A Flavell
Journal:  Immunology       Date:  2017-12-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.